“Biosimilars literally represent a kind of democratization of innovation and open up enormous opportunities” – We are excited to be at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco and are very pleased with the many interesting contacts and meetings. You can listen to and click through the presentation by our CEO Dr. Stefan Glombitza on Formycon as a pure-play biosimilar company here: Facts & Figures – Formycon AG